Prevention and treatment of cytomegalovirus disease in solid organ transplant recipients: the clinical and economic impact of evolving strategies. Introduction.
Pescovitz
Mark D
MD
D019072:Antibiotic Prophylaxis; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D009894:Opportunistic Infections / Q000150:complications / Q000517:prevention & control / Q000821:virology; D016377:Organ Transplantation / Q000009:adverse effects*
D000998:Antiviral Agents